Novel Potent Decameric Peptide of Spirulina platensis Reduces Blood Pressure Levels Through a PI3K/AKT/eNOS-Dependent Mechanism
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Considered as a superfood of the future, Spirulina platensis matrix has been extensively used because of its beneficial effect on the management of cardiovascular diseases. However, its nutraceutical properties, bioactive compounds, and molecular mechanisms are unknown. Here, we demonstrate that S platensis matrix processed in vitro by simulated gastrointestinal digestion induces direct endothelial nitric oxide (NO)-mediated vasorelaxation of resistance vessels in mice. To gain insight into the bioactive compounds responsible for this effect, we used a complex multistep peptidomic approach to fractionate the crude digest: of the 5 peptide fractions identified (A–E), only fraction E evoked vasorelaxation. High-resolution mass spectrometry–based screening revealed in E the presence of 4 main peptides (SP3–SP6 [spirulina peptides]), of which only SP6 (GIVAGDVTPI) exerted direct endothelium-dependent vasodilation of ex vivo vessels, an effect occurring via a PI3K (phosphoinositide-3-kinase)/AKT (serine/threonine kinase Akt) pathway converging on NO release. In vivo, administration of SP6 evoked a significant hemodynamic effect, reducing blood pressure, an action absent in eNOS (endothelial NO synthase)-deficient mice. Of note, although lower doses of SP6 had no hemodynamic effects, it still enhanced endothelial NO vasorelaxation. Finally, in an experimental model of arterial hypertension, SP6 exerted an antihypertensive effect, improving endothelial vasorelaxation associated with enhanced serum nitrite levels. Based on our results, this novel decameric peptide may extend the possible fields of application for spirulina-derived peptides and could be developed into a promising nonpharmacological approach for the containment of pathologies associated with vascular NO misregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional food. Product development, marketing and consumer acceptance—a review
Siró, I., Kápolna, E., Kápolna, B., & Lugasi, A. (2008) · Appetite · doi:10.1016/j.appet.2008.05.060 · Cited by 1,758
Nutritional and therapeutic potential of spirulina
Khan, Z., Bhadouria, P., & Bisen, P. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/138920105774370607 · Cited by 524
Role of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
Parikh, P., Mani, U., & Iyer, U. (2001) · Journal of Medicinal Food · doi:10.1089/10966200152744463 · Cited by 193
Huang, W.-Y., Davidge, S. T., & Wu, J. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.550071 · Cited by 157
Research works printed but not linked: 12
- 10.3390/molecules23051152 · DOI · Paper page
- 10.1080/87559129.2016.1210632 · DOI · Paper page
- 10.1016/j.jchromb.2009.11.033 · DOI · Paper page
- 10.1016/j.jff.2016.08.021 · DOI
- 10.4162/nrp.2008.2.4.295 · DOI · Paper page
- 10.3892/mmr.2017.7602 · DOI
- 10.1021/jf100193f · DOI · Paper page
- 10.1021/acs.jafc.5b02801 · DOI
- 10.1007/s10126-001-0012-7 · DOI · Paper page
- 10.1016/j.foodchem.2011.12.020 · DOI · Paper page
- 10.1161/HYPERTENSIONAHA.111.01009 · DOI · Paper page
- 10.1021/jf1035405 · DOI · Paper page
Cited by
Spirulina for the Food and Functional Food Industries
Lafarga, T., Fernández-Sevilla, J. M., González-López, C., & Acién-Fernández, F. G. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109356 · Cited by 417
Application Progress of Bioactive Compounds in Microalgae on Pharmaceutical and Cosmetics
Zhuang, D., He, N., Khoo, K. S., Ng, E.-P., Chew, K. W., & Ling, T. C. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2021.132932 · Cited by 142
Ramos-Romero, S., Torrella, J. R., Pagès, T., Viscor, G., & Torres, J. L. (2021) · Nutrients · doi:10.3390/nu13020563 · Cited by 134
Spirulina/Arthrospira/Limnospira—Three Names of the Single Organism
Sinetova, M. A., Kupriyanova, E. V., & Los, D. A. (2024) · Foods · doi:10.3390/foods13172762 · Cited by 51
“In fact, it seems that whatever pharmaceutical drug one wants to get from spirulina, he/she can get it, including antioxidant, antidiabetic, immunomodulatory, antihypertensive, and antihyperlipidemic agents [148–152].”
BackgroundSuo, Q., Yue, Y., Wang, J., Wu, N., Geng, L., & Zhang, Q. (2022) · Food & Function · doi:10.1039/d2fo01207c · Cited by 39
Metadata
- Authors
- Carrizzo, A., Conte, G. M., Sommella, E., Damato, A., Ambrosio, M., Sala, M., Scala, M. C., Aquino, R. P., De Lucia, M., Madonna, M., Sansone, F., Ostacolo, C., Capunzo, M., Migliarino, S., Sciarretta, S., Frati, G., Campiglia, P., & Vecchione, C.
- Venue
- Hypertension
- Published
- 2019-02
- Volume
- 73
- Issue
- 2
- Pages
- 449-457
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2907761305
- Cited by
- 84
- References
- 4
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel Potent Decameric Peptide of Spirulina platensis Reduces Blood Pressure Levels Through a PI3K/AKT/eNOS-Dependent Mechanism. https://app.cochat.ai/papers/10.1161/hypertensionaha.118.11801
- The paper
- Carrizzo, A., Conte, G. M., Sommella, E., Damato, A., Ambrosio, M., Sala, M., Scala, M. C., Aquino, R. P., De Lucia, M., Madonna, M., Sansone, F., Ostacolo, C., Capunzo, M., Migliarino, S., Sciarretta, S., Frati, G., Campiglia, P., & Vecchione, C. (2019). Novel Potent Decameric Peptide of Spirulina platensis Reduces Blood Pressure Levels Through a PI3K/AKT/eNOS-Dependent Mechanism. Hypertension. https://doi.org/10.1161/hypertensionaha.118.11801
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.